Engineering Induced Pluripotent Stem Cells for COPD Therapy
Researchers at Oklahoma State havedeveloped a method that can induce 90% differentiation of iPSCs or MSCs intoAECs (type II) under stimulation of proper growth factors and growing on anappropriate matrix. These cells expressed type II cell markers surfactantprotein C and ABCA3, secrete lung surfactant in response to lung surfactantsecretagogues and trans-differentiate into type I AECs. Inaddition, the researchers have demonstrated that the AEC cells attenuated lung injuryin a mouse model of COPD. The potential uses for these cells includecellular-based therapies, drug screening, disease modeling and pulmonary research.
· 90% differentiation efficiency of iPSCs or MSCs into AECs
· Therapeutic for pulmonary diseases, including COPD· Drug discovery· Disease modeling· Pulmonary research· Stem cell research
None
美國
